DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Down 3.6% – Here’s Why

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares traded down 3.6% on Thursday . The stock traded as low as $9.93 and last traded at $9.7740. Approximately 460,905 shares were traded during trading, a decline of 91% from the average session volume of 4,852,365 shares. The stock had previously closed at $10.14.

Analyst Ratings Changes

XRAY has been the subject of a number of analyst reports. Barrington Research set a $15.00 price objective on shares of DENTSPLY SIRONA in a research report on Monday, August 10th. Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd. Piper Sandler boosted their price target on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research report on Wednesday, July 29th. BMO Capital Markets lowered their price objective on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research report on Thursday. Finally, Barclays lifted their price objective on DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research note on Monday, August 24th. Three equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and a consensus target price of $13.31.

DENTSPLY SIRONA Price Performance

The firm’s fifty day moving average price is $11.91 and its 200-day moving average price is $11.49. The stock has a market cap of $1.90 billion, a P/E ratio of -3.47, a PEG ratio of 1.19 and a beta of 0.84. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. The company had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The firm’s revenue for the quarter was down 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.4 earnings per share for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently modified their holdings of the company. Tidal Investments LLC grew its position in shares of DENTSPLY SIRONA by 13.1% during the 2nd quarter. Tidal Investments LLC now owns 371,967 shares of the medical instruments supplier’s stock valued at $3,947,000 after acquiring an additional 43,025 shares during the period. Engineers Gate Manager LP grew its stake in DENTSPLY SIRONA by 451.5% during the second quarter. Engineers Gate Manager LP now owns 124,810 shares of the medical instruments supplier’s stock valued at $1,324,000 after acquiring an additional 102,179 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of DENTSPLY SIRONA in the second quarter worth about $791,000. Allworth Financial LP boosted its position in shares of DENTSPLY SIRONA by 163.8% during the 2nd quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier’s stock valued at $51,000 after acquiring an additional 2,990 shares during the last quarter. Finally, Nykredit A S purchased a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth $38,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.